ArticleJournal for immunotherapy of cancer2019

A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy.

Tongjuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.